Single Article Purchase:
Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction
Jay H. Traverse, MD, Timothy D. Henry, MD, Carl J. Pepine, MD, James T. Willerson, MD, David X. M. Zhao, MD, Stephen G. Ellis, MD, John R. Forder, PhD, R. David Anderson, MD, MS, Antonis K. Hatzopoulos, PhD, Marc S. Penn, MD, PhD, Emerson C. Perin, MD, PhD, Jeffrey Chambers, MD, Kenneth W. Baran, MD, Ganesh Raveendran, MD, Charles Lambert, MD, PhD, Amir Lerman, MD, Daniel I. Simon, MD, Douglas E. Vaughan, MD, Dejian Lai, PhD, Adrian P. Gee, PhD, Doris A. Taylor, PhD, Christopher R. Cogle, MD, James D. Thomas, MD, Rachel E. Olson, RN, MS, Sherry Bowman, RN, Judy Francescon, RN, Carrie Geither, RN, Eileen Handberg, PhD, Casey Kappenman, Lynette Westbrook, RN, Linda B. Piller, MD, MPH, Lara M. Simpson, PhD, Sarah Baraniuk, PhD, Catalin Loghin, MD, David Aguilar, MD, Sara Richman, Claudia Zierold, PhD, Daniel B. Spoon, MD, Judy Bettencourt, MPH, Shelly L. Sayre, MPH, Rachel W. Vojvodic, MPH, Sonia I. Skarlatos, PhD, David J. Gordon, MD, PhD, Ray F. Ebert, PhD, Minjung Kwak, PhD, Lemuel A. Moyé, MD, PhD, Robert D. Simari, MD, for the Cardiovascular Cell Therapy Research Network (CCTRN)
JAMA. 2012;308(22):2380-2389.
Published online December 12, 2012